Jan 9 (Reuters) - U.S. regulators on Wednesday approved a new low-dose hormone intrauterine device designed to prevent pregnancy, the first new device of its type in 12 years, according to Bayer AG.

"Bayer is pleased with the plaintiff's decision to voluntarily dismiss these meritless claims against the Company in Sidhu and believes that the replicated claims raised in the Copeland filing are ...

Development and option to license agreement allows single-handed inserter to be developed and combined with Bayer’s leading hormonal intrauterine systems (IUSs) New inserter has the potential to ...

The original version of this story was published on National Law Journal Approximately 40 lawsuits filed over problems associated with the Mirena intrauterine contraceptive device have been ...

Bayer, a global leader in women’s healthcare, announced the clinical phase III study SUNFLOWER (Study ofUnderstandingNAEH - treatmenteFficacy ofLevonOrgestrel – IUS inWomenElectingnon-suRgical options ...